These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 7738493

  • 1. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H, Jensen JS, Jensen T, Deckert T.
    J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
    [Abstract] [Full Text] [Related]

  • 2. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
    Yokoyama H, Jensen JS, Myrup B, Mathiesen ER, Rønn B, Deckert T.
    Diabetes Care; 1996 May; 19(5):435-40. PubMed ID: 8732705
    [Abstract] [Full Text] [Related]

  • 3. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH.
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [Abstract] [Full Text] [Related]

  • 4. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [Abstract] [Full Text] [Related]

  • 5. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria.
    Crook MA, Earle K, Morocutti A, Yip J, Viberti G, Pickup JC.
    Diabetes Care; 1994 Apr; 17(4):305-10. PubMed ID: 8026286
    [Abstract] [Full Text] [Related]

  • 6. Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus.
    Powrie JK, Watts GF, Crook MA, Ingham JN, Taub NA, Shaw KM.
    Diabet Med; 1996 Mar; 13(3):238-42. PubMed ID: 8689844
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [Abstract] [Full Text] [Related]

  • 8. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD, Agardh E, Torffvit O.
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [Abstract] [Full Text] [Related]

  • 9. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S, Qayyum S, Khan MNA.
    J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
    [Abstract] [Full Text] [Related]

  • 10. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
    Nayak SB, Bhaktha G.
    Lipids Health Dis; 2005 Aug 10; 4():15. PubMed ID: 16092968
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of microalbuminuria in IDDM. A five-year follow-up study.
    Almdal T, Nörgaard K, Feldt-Rasmussen B, Deckert T.
    Diabetes Care; 1994 Feb 10; 17(2):120-5. PubMed ID: 8137681
    [Abstract] [Full Text] [Related]

  • 12. Relationship between serum nitric oxide and sialic acid in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Jawed M, Mahboob T.
    Pak J Pharm Sci; 2013 May 10; 26(3):593-7. PubMed ID: 23625435
    [Abstract] [Full Text] [Related]

  • 13. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Nawab SN, Shaikh R, Mahboob T.
    Pak J Pharm Sci; 2012 Jan 10; 25(1):123-9. PubMed ID: 22186319
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum total renin is insensitive in detecting incipient diabetic nephropathy.
    Matinlauri IH, Rönnemaa T, Koskinen PJ, Aalto MA, Vukari JS, Irjala KM.
    Diabetes Care; 1995 Oct 10; 18(10):1357-61. PubMed ID: 8721937
    [Abstract] [Full Text] [Related]

  • 15. Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.
    Jensen T, Stender S, Deckert T.
    Diabetologia; 1988 Mar 10; 31(3):142-5. PubMed ID: 3371576
    [Abstract] [Full Text] [Related]

  • 16. Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
    Nielsen S, Schmitz A, Bacher T, Rehling M, Ingerslev J, Mogensen CE.
    Diabetologia; 1999 Jan 10; 42(1):60-7. PubMed ID: 10027580
    [Abstract] [Full Text] [Related]

  • 17. Sodium-lithium transport in adolescents with IDDM. Relationship to incipient nephropathy and glycemic control.
    Crompton CH, Balfe JW, Balfe JA, Chatzilias A, Daneman D.
    Diabetes Care; 1994 Jul 10; 17(7):704-10. PubMed ID: 7924781
    [Abstract] [Full Text] [Related]

  • 18. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients.
    Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G.
    Diabetes Care; 1994 Jun 10; 17(6):578-84. PubMed ID: 8082528
    [Abstract] [Full Text] [Related]

  • 19. Monitoring Diabetic Nephropathy by Circulating Gangliosides.
    Ene CD, Penescu M, Anghel A, Neagu M, Budu V, Nicolae I.
    J Immunoassay Immunochem; 2016 Jun 10; 37(1):68-79. PubMed ID: 26359623
    [Abstract] [Full Text] [Related]

  • 20. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
    Jungmann E, Carlberg C, Schallmayer M, Schumm-Draeger PM.
    Med Klin (Munich); 1995 Jul 15; 90(7):383-9. PubMed ID: 7675002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.